ROCKET PHARMACEUTICALS, INC. Quarterly Current Ratio in % from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Rocket Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q3 2015 to Q2 2024.
  • Rocket Pharmaceuticals, Inc. Current Ratio for the quarter ending June 30, 2024 was 959 %, a 2.37% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 959 -23.3 -2.37% Jun 30, 2024
Q1 2024 993 -79.6 -7.42% Mar 31, 2024
Q4 2023 1K -166 -14.2% Dec 31, 2023
Q3 2023 1.06K -337 -24.2% Sep 30, 2023
Q2 2023 982 -618 -38.6% Jun 30, 2023
Q1 2023 1.07K -619 -36.6% Mar 31, 2023
Q4 2022 1.17K -361 -23.7% Dec 31, 2022
Q3 2022 1.39K -81 -5.49% Sep 30, 2022
Q2 2022 1.6K +357 +28.7% Jun 30, 2022
Q1 2022 1.69K +540 +46.9% Mar 31, 2022
Q4 2021 1.53K +347 +29.4% Dec 31, 2021
Q3 2021 1.47K +306 +26.2% Sep 30, 2021
Q2 2021 1.24K -79.4 -6% Jun 30, 2021
Q1 2021 1.15K -279 -19.5% Mar 31, 2021
Q4 2020 1.18K -155 -11.6% Dec 31, 2020
Q3 2020 1.17K -84.9 -6.77% Sep 30, 2020
Q2 2020 1.32K +16.3 +1.25% Jun 30, 2020
Q1 2020 1.43K +238 +20% Mar 31, 2020
Q4 2019 1.34K -188 -12.4% Dec 31, 2019
Q3 2019 1.25K -193 -13.3% Sep 30, 2019
Q2 2019 1.31K -410 -23.9% Jun 30, 2019
Q1 2019 1.19K -933 -43.9% Mar 31, 2019
Q4 2018 1.52K -464 -23.4% Dec 31, 2018
Q3 2018 1.45K -836 -36.6% Sep 30, 2018
Q2 2018 1.72K -501 -22.6% Jun 30, 2018
Q1 2018 2.13K -36.2 -1.68% Mar 31, 2018
Q4 2017 1.99K -177 -8.2% Dec 31, 2017
Q3 2017 2.28K -132 -5.46% Sep 30, 2017
Q2 2017 2.22K -481 -17.8% Jun 30, 2017
Q1 2017 2.16K -498 -18.7% Mar 31, 2017
Q4 2016 2.17K -556 -20.4% Dec 31, 2016
Q3 2016 2.41K +946 +64.4% Sep 30, 2016
Q2 2016 2.7K Jun 30, 2016
Q1 2016 2.66K Mar 31, 2016
Q4 2015 2.72K Dec 31, 2015
Q3 2015 1.47K Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.